ArticleACS pharmacology & translational science2022

Second-Generation Prostaglandin Receptor EP2 Antagonist, TG8-260, with High Potency, Selectivity, Oral Bioavailability, and Anti-Inflammatory Properties.

Radhika Amaradhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.